Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 11.38 is 36% above its 5-year average of 8.35, near the high end of its 5-year range (5.88–11.38).
9.74% above its 12-month average of 10.37.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 4.10.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-19T00:15:36.215Z. Historical observations retain their original dates. Historical series through 2026-09-11.
EARNINGS PER SHARE (EPS)
11.38
EARNINGS PER SHARE (EPS) AVG TTM
10.37
EARNINGS PER SHARE (EPS) AVG 3Y
8.56
EARNINGS PER SHARE (EPS) AVG 5Y
8.35
EARNINGS PER SHARE (EPS) AVG 10Y
6.29
EARNINGS PER SHARE (EPS) AVG 15Y
5.18
EARNINGS PER SHARE (EPS) AVG 20Y
4.34
CURRENT VS TTM AVG
+9.74%
CURRENT VS 3Y AVG
+32.94%
CURRENT VS 5Y AVG
+36.34%
CURRENT VS 10Y AVG
+81.03%
CURRENT VS 15Y AVG
+119.66%
CURRENT VS 20Y AVG
+162.50%
Market Cap
$11.79B
Earnings Per Share (EPS)
-2.04
TTM Avg
-1.51
3Y Avg
-0.65
5Y Avg
0.36
Market Cap
$12.08B
Earnings Per Share (EPS)
6.14
TTM Avg
5.08
3Y Avg
4.10
5Y Avg
3.91
Market Cap
$11.33B
Earnings Per Share (EPS)
1.16
TTM Avg
0.82
3Y Avg
1.13
5Y Avg
1.19
Market Cap
$10.78B
Earnings Per Share (EPS)
2.93
TTM Avg
1.92
3Y Avg
1.82
5Y Avg
4.51
Market Cap
$10.70B
Earnings Per Share (EPS)
24.38
TTM Avg
20.29
3Y Avg
15.04
5Y Avg
13.87
Market Cap
$10.57B
Earnings Per Share (EPS)
5.76
TTM Avg
5.64
3Y Avg
5.43
5Y Avg
9.01
Market Cap
$10.48B
Earnings Per Share (EPS)
0.19
TTM Avg
14.72
3Y Avg
15.46
5Y Avg
14.11
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DaVita Inc. (DVA) | $11.80B | 11.38 | 10.37 | 8.56 | 8.35 |
| Baxter International Inc. (BAX)vs › | $11.79B | -2.04 | -1.51 | -0.65 | 0.36 |
| Encompass Health Corporation (EHC)vs › | $12.08B | 6.14 | 5.08 | 4.10 | 3.91 |
| Bio-Techne Corporation (TECH)vs › | $11.33B | 1.16 | 0.82 | 1.13 | 1.19 |
| Penumbra, Inc. (PEN)vs › | $12.51B | 4.07 | 2.47 | 1.81 | 1.14 |
| The Cooper Companies, Inc. (COO)vs › | $10.78B | 2.93 | 1.92 | 1.82 | 4.51 |
| Universal Health Services, Inc. (UHS)vs › | $10.70B | 24.38 | 20.29 | 15.04 | 13.87 |
| Align Technology, Inc. (ALGN)vs › | $10.57B | 5.76 | 5.64 | 5.43 | 9.01 |
| Molina Healthcare, Inc. (MOH)vs › | $10.48B | 0.19 | 14.72 | 15.46 | 14.11 |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.39B | -4.85 | -1.35 | 4.03 | 5.21 |
Trailing EPS (TTM)
$11.38
Forward EPS (Est.)
$14.85
P/E Ratio
16.2
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 9.72 |
| 2024-12-31 | 11.02 |
| 2023-12-31 | 7.62 |
| 2022-12-31 | 5.88 |
| 2021-12-31 | 9.30 |
| 2020-12-31 | 6.54 |
| 2019-12-31 | 5.29 |
| 2018-12-31 | 4.63 |
| 2017-12-31 | 3.52 |
| 2016-12-31 | 4.36 |
| 2015-12-31 | 1.27 |
| 2014-12-31 | 3.41 |
| 2013-12-31 | 3.02 |
| 2012-12-31 | 2.79 |
| 2011-12-31 | 2.52 |
| 2010-12-31 | 2.00 |
| 2009-12-31 | 2.04 |
| 2008-12-31 | 1.78 |
| 2007-12-31 | 1.80 |
| 2006-12-31 | 1.40 |
| 2005-12-31 | 1.13 |
| 2004-12-31 | 1.13 |
| 2003-12-31 | 0.93 |
| 2002-12-31 | 0.73 |
| 2001-12-31 | 0.55 |
| 2000-12-31 | 0.06 |
| 1999-12-31 | -0.60 |
| 1998-12-31 | -0.02 |
| 1997-12-31 | 0.24 |
| 1996-12-31 | 0.14 |
